Form 8-K - Current report:
SEC Accession No. 0001558370-22-018014
Filing Date
2022-11-17
Accepted
2022-11-17 07:06:55
Documents
14
Period of Report
2022-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20221116x8k.htm   iXBRL 8-K 60723
2 EX-99.1 mrns-20221116xex99d1.htm EX-99.1 20096
3 GRAPHIC mrns-20221116xex99d1001.jpg GRAPHIC 8659
  Complete submission text file 0001558370-22-018014.txt   227167

Data Files

Seq Description Document Type Size
4 EX-101.SCH mrns-20221116.xsd EX-101.SCH 3119
5 EX-101.LAB mrns-20221116_lab.xml EX-101.LAB 16592
6 EX-101.PRE mrns-20221116_pre.xml EX-101.PRE 10714
8 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20221116x8k_htm.xml XML 5113
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 221396817
SIC: 2834 Pharmaceutical Preparations